FDA Accepts PharmaTher's New Drug Application for KETARX™ (Ketamine)

Wed, Sep 27

Perspectives

The FDA has accepted @Pharmather_Inc Abbreviated New Drug Application for KETARX™ (racemic ketamine). The goal date for this priority ANDA is April 29, 2024. https://t.co/E842AuYJf1

4615

The FDA has accepted the company’s Abbreviated New Drug Application for KETARX™ (racemic ketamine). The goal date for this priority original ANDA of April 29, 2024.

Discover